The following session took place during the 2025 Mid-Atlantic Bankruptcy Workshop in August 2025. The Supreme Court’s decision in Purdue Pharma has significant implications for cross-border insolvency practice under chapter 15. This panel will examine how the ruling is reshaping the legal landscape for foreign main proceedings, recognition standards, and especially the use of nonconsensual third-party releases. The panelists also will explore emerging questions around comity, enforcement of foreign judgments, and the limits of U.S. bankruptcy courts’ authority in cross-border cases. All sessions from this conference can be accessed at https://cle.abi.org/.
Materials are available here.
Speakers:
K. Elizabeth Sieg, Moderator
McGuireWoods LLP | Richmond, Va.
Steven W. Golden
Pachulski Stang Ziehl & Jones LLP | Wilmington, Del.
L. Katherine Good Esq.
Potter Anderson & Corroon LLP | Wilmington, Del.
Thomas M. Horan
U.S. Bankruptcy Court | Wilmington, Del.
Matthew P. Ward
Womble Bond Dickinson (US) LLP | Wilmington, Del.
Christopher Burton Wick
Hahn Loeser & Parks LLP | Cleveland, Ohio
This content is reserved for Global Insolvency Members or members of the American Bankruptcy Institute. Create an account now to gain access. Enjoy free membership for a limited time.
Already a member? Login here.